HEADER    ENDOCYTOSIS/EXOCYTOSIS                  04-FEB-02   1KYF              
TITLE     AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPS15 DPF       
TITLE    2 PEPTIDE                                                              
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: ALPHA-ADAPTIN C;                                           
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: C-TERMINAL APPENDAGE (EAR) RESIDUES 701-938;               
COMPND   5 SYNONYM: AP-2 CLATHRIN ADAPTOR ALPHA SUBUNIT;                        
COMPND   6 ENGINEERED: YES;                                                     
COMPND   7 MOL_ID: 2;                                                           
COMPND   8 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR SUBSTRATE 15;             
COMPND   9 CHAIN: P;                                                            
COMPND  10 FRAGMENT: RESIDUES 628-632;                                          
COMPND  11 SYNONYM: PROTEIN EPS15, AF-1P PROTEIN;                               
COMPND  12 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: MUS MUSCULUS;                                   
SOURCE   3 ORGANISM_COMMON: HOUSE MOUSE;                                        
SOURCE   4 ORGANISM_TAXID: 10090;                                               
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   7 EXPRESSION_SYSTEM_STRAIN: BL4;                                       
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   9 EXPRESSION_SYSTEM_PLASMID: PGEX-2T;                                  
SOURCE  10 MOL_ID: 2;                                                           
SOURCE  11 SYNTHETIC: YES;                                                      
SOURCE  12 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. IT IS         
SOURCE  13 NATURALLY OCCURING SEQUENCE IN MUS MUSCULUS (MOUSE) EPS15            
KEYWDS    PROTEIN-PEPTIDE COMPLEX, ENDOCYTOSIS, ENDOCYTOSIS-EXOCYTOSIS COMPLEX  
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    T.J.BRETT,L.M.TRAUB,D.H.FREMONT                                       
REVDAT   4   11-OCT-17 1KYF    1       REMARK                                   
REVDAT   3   24-FEB-09 1KYF    1       VERSN                                    
REVDAT   2   01-APR-03 1KYF    1       JRNL                                     
REVDAT   1   12-JUN-02 1KYF    0                                                
JRNL        AUTH   T.J.BRETT,L.M.TRAUB,D.H.FREMONT                              
JRNL        TITL   ACCESSORY PROTEIN RECRUITMENT MOTIFS IN CLATHRIN-MEDIATED    
JRNL        TITL 2 ENDOCYTOSIS.                                                 
JRNL        REF    STRUCTURE                     V.  10   797 2002              
JRNL        REFN                   ISSN 0969-2126                               
JRNL        PMID   12057195                                                     
JRNL        DOI    10.1016/S0969-2126(02)00784-0                                
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.22 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.22                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 20.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 94.4                           
REMARK   3   CROSS-VALIDATION METHOD           : FREE R                         
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.154                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.153                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : 0.211                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100                  
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : 3427                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 67213                  
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : 0.135                  
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : 0.133                  
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : 0.191                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.100                  
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : 2527                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 49261                  
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 1999                                          
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 0                                             
REMARK   3   SOLVENT ATOMS      : 343                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : 2342.0                  
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : 1897.0                  
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : 0                       
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 19156                   
REMARK   3   NUMBER OF RESTRAINTS                     : 22808                   
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.012                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.031                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000                   
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.030                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.065                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.076                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.018                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.004                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.058                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.000                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: MOEWS & KRETSINGER,J.MOL.BIOL.91(1973)201-22          
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER                        
REMARK   3   SPECIAL CASE: ANISOTROPIC REFINEMENT REDUCED FREE R                
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1KYF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-FEB-02.                  
REMARK 100 THE DEPOSITION ID IS D_1000015466.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 01-JUN-00                          
REMARK 200  TEMPERATURE           (KELVIN) : 110.0                              
REMARK 200  PH                             : NULL                               
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : NSLS                               
REMARK 200  BEAMLINE                       : X25                                
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.10                               
REMARK 200  MONOCHROMATOR                  : SI 111 CHANNEL                     
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 4                     
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 67213                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.220                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 50.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 94.5                               
REMARK 200  DATA REDUNDANCY                : 6.000                              
REMARK 200  R MERGE                    (I) : NULL                               
REMARK 200  R SYM                      (I) : 0.05900                            
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 15.6000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.22                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.26                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 84.0                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 3.50                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : 0.38800                            
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 2.300                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: SHELX                                                 
REMARK 200 STARTING MODEL: PDB ENTRY 1QTS                                       
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 32.60                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.83                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL                                     
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1                         
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y+1/2,-Z                                             
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000       36.41000            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, P                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     GLY P   627                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ARG A 707   CD  -  NE  -  CZ  ANGL. DEV. =  52.5 DEGREES          
REMARK 500    ARG A 707   NE  -  CZ  -  NH1 ANGL. DEV. =   4.5 DEGREES          
REMARK 500    ARG A 736   NE  -  CZ  -  NH2 ANGL. DEV. =  -3.1 DEGREES          
REMARK 500    PHE A 749   CB  -  CG  -  CD1 ANGL. DEV. =   4.3 DEGREES          
REMARK 500    ARG A 806   CD  -  NE  -  CZ  ANGL. DEV. =  23.6 DEGREES          
REMARK 500    ARG A 806   NE  -  CZ  -  NH1 ANGL. DEV. =   5.7 DEGREES          
REMARK 500    ARG A 806   NE  -  CZ  -  NH2 ANGL. DEV. =  -4.8 DEGREES          
REMARK 500    PHE A 836   CB  -  CG  -  CD2 ANGL. DEV. =   4.3 DEGREES          
REMARK 500    ARG A 920   NE  -  CZ  -  NH1 ANGL. DEV. =   4.3 DEGREES          
REMARK 500    ARG A 920   NE  -  CZ  -  NH2 ANGL. DEV. =  -3.9 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    SER A 693      103.95     -7.01                                   
REMARK 500    GLU A 702       28.17   -140.77                                   
REMARK 500    ASN A 719     -160.70   -104.76                                   
REMARK 500    GLN A 732     -135.29     54.03                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1QTP   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE       
REMARK 900 RELATED ID: 1QTS   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF THE AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE       
REMARK 900 RELATED ID: 1KY6   RELATED DB: PDB                                   
REMARK 900 AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPSIN DPW      
REMARK 900 PEPTIDE                                                              
REMARK 900 RELATED ID: 1KY7   RELATED DB: PDB                                   
REMARK 900 THE AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH            
REMARK 900 AMPHIPHYSIN FXDXF                                                    
REMARK 900 RELATED ID: 1KYD   RELATED DB: PDB                                   
REMARK 900 AP-2 CLATHRIN ADAPTOR ALPHA-APPENDAGE IN COMPLEX WITH EPSIN DPW      
REMARK 900 PEPTIDE                                                              
DBREF  1KYF A  701   938  UNP    P17427   AP2A2_MOUSE    701    938             
DBREF  1KYF P  627   632  UNP    P42567   EP15_MOUSE     627    632             
SEQADV 1KYF GLY A  692  UNP  P17427              CLONING ARTIFACT               
SEQADV 1KYF SER A  693  UNP  P17427              CLONING ARTIFACT               
SEQADV 1KYF PRO A  694  UNP  P17427              CLONING ARTIFACT               
SEQADV 1KYF GLY A  695  UNP  P17427              CLONING ARTIFACT               
SEQADV 1KYF ILE A  696  UNP  P17427              CLONING ARTIFACT               
SEQADV 1KYF ARG A  697  UNP  P17427              CLONING ARTIFACT               
SEQADV 1KYF LEU A  698  UNP  P17427              CLONING ARTIFACT               
SEQADV 1KYF GLY A  699  UNP  P17427              CLONING ARTIFACT               
SEQADV 1KYF SER A  700  UNP  P17427              CLONING ARTIFACT               
SEQRES   1 A  247  GLY SER PRO GLY ILE ARG LEU GLY SER SER GLU ASP ASN          
SEQRES   2 A  247  PHE ALA ARG PHE VAL CYS LYS ASN ASN GLY VAL LEU PHE          
SEQRES   3 A  247  GLU ASN GLN LEU LEU GLN ILE GLY LEU LYS SER GLU PHE          
SEQRES   4 A  247  ARG GLN ASN LEU GLY ARG MET PHE ILE PHE TYR GLY ASN          
SEQRES   5 A  247  LYS THR SER THR GLN PHE LEU ASN PHE THR PRO THR LEU          
SEQRES   6 A  247  ILE CYS ALA ASP ASP LEU GLN THR ASN LEU ASN LEU GLN          
SEQRES   7 A  247  THR LYS PRO VAL ASP PRO THR VAL ASP GLY GLY ALA GLN          
SEQRES   8 A  247  VAL GLN GLN VAL VAL ASN ILE GLU CYS ILE SER ASP PHE          
SEQRES   9 A  247  THR GLU ALA PRO VAL LEU ASN ILE GLN PHE ARG TYR GLY          
SEQRES  10 A  247  GLY THR PHE GLN ASN VAL SER VAL LYS LEU PRO ILE THR          
SEQRES  11 A  247  LEU ASN LYS PHE PHE GLN PRO THR GLU MET ALA SER GLN          
SEQRES  12 A  247  ASP PHE PHE GLN ARG TRP LYS GLN LEU SER ASN PRO GLN          
SEQRES  13 A  247  GLN GLU VAL GLN ASN ILE PHE LYS ALA LYS HIS PRO MET          
SEQRES  14 A  247  ASP THR GLU ILE THR LYS ALA LYS ILE ILE GLY PHE GLY          
SEQRES  15 A  247  SER ALA LEU LEU GLU GLU VAL ASP PRO ASN PRO ALA ASN          
SEQRES  16 A  247  PHE VAL GLY ALA GLY ILE ILE HIS THR LYS THR THR GLN          
SEQRES  17 A  247  ILE GLY CYS LEU LEU ARG LEU GLU PRO ASN LEU GLN ALA          
SEQRES  18 A  247  GLN MET TYR ARG LEU THR LEU ARG THR SER LYS ASP THR          
SEQRES  19 A  247  VAL SER GLN ARG LEU CYS GLU LEU LEU SER GLU GLN PHE          
SEQRES   1 P    6  GLY SER ASP PRO PHE LYS                                      
FORMUL   3  HOH   *343(H2 O)                                                    
HELIX    1   1 ASN A  704  VAL A  709  5                                   6    
HELIX    2   2 ALA A  759  ASN A  765  1                                   7    
HELIX    3   3 THR A  821  LYS A  824  5                                   4    
HELIX    4   4 ALA A  832  LYS A  841  1                                  10    
HELIX    5   5 ASN A  845  GLN A  847  5                                   3    
HELIX    6   6 ASP A  861  GLY A  873  1                                  13    
HELIX    7   7 LYS A  923  GLU A  936  1                                  14    
SHEET    1   A 5 GLY A 714  GLU A 718  0                                        
SHEET    2   A 5 LEU A 722  ARG A 731 -1  O  ILE A 724   N  PHE A 717           
SHEET    3   A 5 LEU A 734  ASN A 743 -1  O  PHE A 738   N  LYS A 727           
SHEET    4   A 5 GLN A 782  CYS A 791 -1  O  VAL A 783   N  TYR A 741           
SHEET    5   A 5 LEU A 766  THR A 770 -1  N  GLN A 769   O  ASN A 788           
SHEET    1   B 3 LEU A 750  ILE A 757  0                                        
SHEET    2   B 3 VAL A 800  TYR A 807 -1  O  VAL A 800   N  ILE A 757           
SHEET    3   B 3 THR A 810  LYS A 817 -1  O  VAL A 816   N  LEU A 801           
SHEET    1   C 5 GLU A 849  LYS A 855  0                                        
SHEET    2   C 5 MET A 914  THR A 921 -1  O  LEU A 919   N  VAL A 850           
SHEET    3   C 5 GLN A 899  ASN A 909 -1  N  ASN A 909   O  MET A 914           
SHEET    4   C 5 PHE A 887  HIS A 894 -1  N  GLY A 891   O  CYS A 902           
SHEET    5   C 5 PHE A 826  PRO A 828 -1  N  GLN A 827   O  ILE A 892           
SHEET    1   D 5 GLU A 849  LYS A 855  0                                        
SHEET    2   D 5 MET A 914  THR A 921 -1  O  LEU A 919   N  VAL A 850           
SHEET    3   D 5 GLN A 899  ASN A 909 -1  N  ASN A 909   O  MET A 914           
SHEET    4   D 5 PHE A 887  HIS A 894 -1  N  GLY A 891   O  CYS A 902           
SHEET    5   D 5 ALA A 875  LEU A 877 -1  N  LEU A 877   O  VAL A 888           
CRYST1   40.620   72.820   41.860  90.00  99.95  90.00 P 1 21 1      2          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.024618  0.000000  0.004319        0.00000                         
SCALE2      0.000000  0.013732  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.024254        0.00000                         
ATOM      2  CA  GLY A 692      -3.172  -7.091  -8.578  1.00 69.03           C  
ATOM     11  CA  SER A 693      -6.268  -8.469  -6.750  1.00 55.98           C  
ATOM     21  CA  PRO A 694      -9.283  -7.547  -8.930  1.00 41.47           C  
ATOM     35  CA  GLY A 695     -12.336  -5.579  -7.979  1.00 27.91           C  
ATOM     42  CA  ILE A 696     -13.072  -2.449  -6.023  1.00 23.95           C  
ATOM     61  CA  ARG A 697     -10.654  -1.608  -3.111  1.00 26.50           C  
ATOM     83  CA  LEU A 698     -13.361  -0.334  -0.744  1.00 17.71           C  
ATOM    102  CA  GLY A 699     -14.385  -2.527   2.165  1.00 24.66           C  
ATOM    109  CA  SER A 700     -11.321  -4.605   1.270  1.00 20.05           C  
ATOM    119  CA  SER A 701      -8.459  -5.899   3.424  1.00 21.71           C  
ATOM    129  CA  GLU A 702      -6.207  -3.161   2.023  1.00 20.09           C  
ATOM    144  CA  ASP A 703      -8.176   0.053   1.654  1.00 20.87           C  
ATOM    156  CA  ASN A 704      -5.503   2.229   3.320  1.00 17.29           C  
ATOM    170  CA  PHE A 705      -2.331   0.109   3.009  1.00 16.76           C  
ATOM    190  CA  ALA A 706      -0.569   2.455   0.611  1.00 19.02           C  
ATOM    200  CA  ARG A 707      -0.836   5.365   3.067  1.00 17.96           C  
ATOM    223  CA  PHE A 708       1.574   3.542   5.381  1.00 14.86           C  
ATOM    243  CA  VAL A 709       4.573   2.940   3.069  1.00 15.23           C  
ATOM    259  CA  CYS A 710       6.167   6.388   3.456  1.00 16.27           C  
ATOM    269  CA  LYS A 711       4.841   7.065   6.955  1.00 16.06           C  
ATOM    291  CA  ASN A 712       4.360   4.944  10.032  1.00 18.28           C  
ATOM    305  CA  ASN A 713       1.511   6.644  11.925  1.00 16.77           C  
ATOM    319  CA  GLY A 714      -2.218   6.943  11.351  1.00 17.58           C  
ATOM    326  CA  VAL A 715      -5.503   5.123  11.063  1.00 14.65           C  
ATOM    342  CA  LEU A 716      -5.216   1.871   9.165  1.00 15.56           C  
ATOM    361  CA  PHE A 717      -8.851   0.779   9.381  1.00 12.85           C  
ATOM    381  CA  GLU A 718     -12.127   2.080  10.734  1.00 14.05           C  
ATOM    396  CA  ASN A 719     -15.557   0.480  10.562  1.00 13.72           C  
ATOM    410  CA  GLN A 720     -18.558   1.538  12.623  1.00 12.95           C  
ATOM    427  CA  LEU A 721     -17.408  -0.391  15.702  1.00 13.68           C  
ATOM    446  CA  LEU A 722     -13.612  -0.398  15.679  1.00 14.15           C  
ATOM    465  CA  GLN A 723     -10.768   1.907  14.784  1.00 15.17           C  
ATOM    482  CA  ILE A 724      -7.271   0.436  14.220  1.00 13.23           C  
ATOM    501  CA  GLY A 725      -4.420   2.895  14.555  1.00 13.20           C  
ATOM    508  CA  LEU A 726      -0.696   2.402  14.096  1.00 12.90           C  
ATOM    527  CA  LYS A 727       2.554   3.857  15.319  1.00 13.12           C  
ATOM    549  CA  SER A 728       5.828   2.203  14.302  1.00 14.86           C  
ATOM    559  CA  GLU A 729       9.580   2.643  14.521  1.00 15.82           C  
ATOM    574  CA  PHE A 730      12.338   0.733  12.670  1.00 14.46           C  
ATOM    594  CA  ARG A 731      16.071   0.339  13.134  1.00 14.33           C  
ATOM    616  CA  GLN A 732      18.445  -2.014  11.337  1.00 13.02           C  
ATOM    633  CA  ASN A 733      16.425  -5.154  10.353  1.00 13.68           C  
ATOM    647  CA  LEU A 734      14.072  -4.631  13.274  1.00 13.42           C  
ATOM    666  CA  GLY A 735      10.931  -2.740  14.169  1.00 15.36           C  
ATOM    673  CA  ARG A 736       8.330  -2.158  16.845  1.00 14.34           C  
ATOM    695  CA  MET A 737       4.692  -1.599  15.755  1.00 14.82           C  
ATOM    712  CA  PHE A 738       2.024  -0.417  18.187  1.00 14.85           C  
ATOM    732  CA  ILE A 739      -1.484  -1.340  17.120  1.00 12.37           C  
ATOM    751  CA  PHE A 740      -4.289   0.630  18.729  1.00 13.47           C  
ATOM    771  CA  TYR A 741      -7.759  -0.929  18.960  1.00 14.90           C  
ATOM    791  CA  GLY A 742     -10.424   1.667  19.624  1.00 15.03           C  
ATOM    798  CA  ASN A 743     -13.975   0.739  20.633  1.00 13.65           C  
ATOM    812  CA  LYS A 744     -16.177   3.376  19.037  1.00 15.31           C  
ATOM    834  CA  THR A 745     -19.318   2.124  20.815  1.00 16.13           C  
ATOM    847  CA  SER A 746     -20.860   2.445  24.231  1.00 18.39           C  
ATOM    857  CA  THR A 747     -20.685  -1.321  24.968  1.00 17.72           C  
ATOM    870  CA  GLN A 748     -17.818  -3.695  25.694  1.00 19.21           C  
ATOM    887  CA  PHE A 749     -16.168  -5.914  23.230  1.00 17.15           C  
ATOM    907  CA  LEU A 750     -15.672  -9.458  24.593  1.00 15.78           C  
ATOM    926  CA  ASN A 751     -13.179 -12.174  23.656  1.00 17.04           C  
ATOM    940  CA  PHE A 752     -11.227  -9.520  21.689  1.00 14.63           C  
ATOM    960  CA  THR A 753      -8.539 -11.496  19.888  1.00 14.48           C  
ATOM    973  CA  PRO A 754      -6.121 -10.021  17.304  1.00 15.37           C  
ATOM    987  CA  THR A 755      -3.836 -12.450  15.477  1.00 17.18           C  
ATOM   1000  CA  LEU A 756      -1.027 -11.922  13.029  1.00 18.75           C  
ATOM   1019  CA  ILE A 757      -0.794 -14.266  10.055  1.00 18.52           C  
ATOM   1038  CA  CYS A 758       2.090 -14.497   7.554  1.00 21.58           C  
ATOM   1048  CA  ALA A 759       1.605 -16.438   4.300  1.00 34.38           C  
ATOM   1058  CA  ASP A 760       4.104 -19.211   3.593  1.00 47.42           C  
ATOM   1070  CA  ASP A 761       7.146 -17.440   2.045  1.00 44.26           C  
ATOM   1082  CA  LEU A 762       6.520 -14.554   4.373  1.00 21.52           C  
ATOM   1101  CA  GLN A 763       6.988 -16.882   7.355  1.00 33.63           C  
ATOM   1118  CA  THR A 764      10.568 -17.437   6.312  1.00 28.86           C  
ATOM   1131  CA  ASN A 765      11.361 -13.794   5.653  1.00 18.67           C  
ATOM   1145  CA  LEU A 766       9.672 -11.994   8.525  1.00 17.48           C  
ATOM   1164  CA  ASN A 767       9.434 -12.923  12.186  1.00 17.86           C  
ATOM   1178  CA  LEU A 768       6.720 -11.260  14.265  1.00 17.48           C  
ATOM   1197  CA  GLN A 769       6.434 -11.572  18.063  1.00 20.91           C  
ATOM   1214  CA  THR A 770       3.626 -10.207  20.163  1.00 23.10           C  
ATOM   1227  CA  LYS A 771       1.888 -10.721  23.521  1.00 34.63           C  
ATOM   1249  CA  PRO A 772      -1.807 -11.361  24.229  1.00 38.79           C  
ATOM   1263  CA  VAL A 773      -4.074  -8.298  24.493  1.00 26.16           C  
ATOM   1279  CA  ASP A 774      -6.802  -8.138  27.245  1.00 31.43           C  
ATOM   1291  CA  PRO A 775      -9.915  -9.597  25.664  1.00 24.01           C  
ATOM   1305  CA  THR A 776     -12.353  -7.123  27.234  1.00 20.16           C  
ATOM   1318  CA  VAL A 777     -12.404  -3.630  25.684  1.00 17.54           C  
ATOM   1334  CA  ASP A 778     -14.688  -1.042  27.265  1.00 17.81           C  
ATOM   1346  CA  GLY A 779     -16.837   1.182  25.139  1.00 16.02           C  
ATOM   1353  CA  GLY A 780     -14.822   4.259  24.222  1.00 18.63           C  
ATOM   1360  CA  ALA A 781     -11.568   2.688  25.268  1.00 17.81           C  
ATOM   1370  CA  GLN A 782      -8.439   1.774  23.410  1.00 21.95           C  
ATOM   1387  CA  VAL A 783      -6.249  -1.307  23.932  1.00 23.73           C  
ATOM   1403  CA  GLN A 784      -2.701  -1.597  22.569  1.00 16.92           C  
ATOM   1420  CA  GLN A 785      -0.727  -4.434  21.072  1.00 17.51           C  
ATOM   1437  CA  VAL A 786       3.005  -4.305  20.515  1.00 17.90           C  
ATOM   1453  CA  VAL A 787       4.444  -6.228  17.627  1.00 15.17           C  
ATOM   1469  CA  ASN A 788       8.185  -6.880  17.620  1.00 15.25           C  
ATOM   1483  CA  ILE A 789       9.409  -7.256  14.023  1.00 13.25           C  
ATOM   1502  CA  GLU A 790      12.533  -8.917  12.615  1.00 13.76           C  
ATOM   1517  CA  CYS A 791      13.314  -8.980   8.922  1.00 13.94           C  
ATOM   1527  CA  ILE A 792      15.084 -12.207   8.032  1.00 15.46           C  
ATOM   1546  CA  SER A 793      15.400 -11.635   4.272  1.00 16.31           C  
ATOM   1556  CA  ASP A 794      13.704  -9.443   1.641  1.00 14.21           C  
ATOM   1568  CA  PHE A 795       9.972  -9.983   1.147  1.00 14.88           C  
ATOM   1588  CA  THR A 796       6.995  -8.838  -0.923  1.00 15.11           C  
ATOM   1601  CA  GLU A 797       3.844 -10.090   0.857  1.00 17.17           C  
ATOM   1616  CA  ALA A 798       2.338  -8.353   3.864  1.00 17.46           C  
ATOM   1626  CA  PRO A 799       1.143  -9.958   7.106  1.00 16.33           C  
ATOM   1640  CA  VAL A 800      -2.605 -10.145   7.790  1.00 16.72           C  
ATOM   1656  CA  LEU A 801      -4.063  -8.818  10.992  1.00 15.54           C  
ATOM   1675  CA  ASN A 802      -7.170 -10.805  11.881  1.00 15.66           C  
ATOM   1689  CA  ILE A 803      -9.439  -9.505  14.636  1.00 14.34           C  
ATOM   1708  CA  GLN A 804     -12.252 -11.471  16.166  1.00 15.74           C  
ATOM   1725  CA  PHE A 805     -14.510 -10.270  18.969  1.00 14.00           C  
ATOM   1745  CA  ARG A 806     -18.015 -10.421  20.362  1.00 17.87           C  
ATOM   1767  CA  TYR A 807     -20.253  -7.352  20.261  1.00 19.28           C  
ATOM   1787  CA  GLY A 808     -23.754  -7.681  21.516  1.00 35.08           C  
ATOM   1794  CA  GLY A 809     -23.534 -11.484  21.303  1.00 37.47           C  
ATOM   1801  CA  THR A 810     -22.612 -11.251  17.652  1.00 19.35           C  
ATOM   1814  CA  PHE A 811     -19.455 -12.532  16.014  1.00 17.55           C  
ATOM   1834  CA  GLN A 812     -17.390  -9.679  14.580  1.00 14.16           C  
ATOM   1851  CA  ASN A 813     -14.501 -10.553  12.244  1.00 14.70           C  
ATOM   1865  CA  VAL A 814     -12.085  -8.120  10.557  1.00 15.61           C  
ATOM   1881  CA  SER A 815      -9.033  -8.893   8.385  1.00 16.12           C  
ATOM   1891  CA  VAL A 816      -6.656  -6.118   7.208  1.00 17.34           C  
ATOM   1907  CA  LYS A 817      -3.221  -6.178   5.672  1.00 15.61           C  
ATOM   1929  CA  LEU A 818      -0.559  -4.810   7.933  1.00 14.27           C  
ATOM   1948  CA  PRO A 819       1.867  -2.278   6.376  1.00 14.37           C  
ATOM   1962  CA  ILE A 820       5.207  -3.895   7.086  1.00 13.59           C  
ATOM   1981  CA  THR A 821       7.051  -3.297   3.837  1.00 13.49           C  
ATOM   1994  CA  LEU A 822      10.622  -3.848   2.776  1.00 13.36           C  
ATOM   2013  CA  ASN A 823      11.539  -0.184   2.702  1.00 12.54           C  
ATOM   2027  CA  LYS A 824      10.950   0.048   6.463  1.00 13.14           C  
ATOM   2049  CA  PHE A 825      14.366  -1.624   6.904  1.00 12.04           C  
ATOM   2069  CA  PHE A 826      16.323   1.201   5.183  1.00 12.07           C  
ATOM   2089  CA  GLN A 827      19.433   2.838   6.528  1.00 12.50           C  
ATOM   2106  CA  PRO A 828      19.875   6.147   4.673  1.00 14.17           C  
ATOM   2120  CA  THR A 829      23.381   6.556   3.281  1.00 16.65           C  
ATOM   2133  CA  GLU A 830      24.527  10.061   2.504  1.00 19.19           C  
ATOM   2148  CA  MET A 831      27.388  10.252   0.051  1.00 22.06           C  
ATOM   2165  CA  ALA A 832      29.067  12.586  -2.434  1.00 29.79           C  
ATOM   2175  CA  SER A 833      28.159  12.613  -6.065  1.00 28.62           C  
ATOM   2185  CA  GLN A 834      31.479  10.961  -7.115  1.00 27.48           C  
ATOM   2202  CA  ASP A 835      30.887   8.087  -4.731  1.00 21.49           C  
ATOM   2214  CA  PHE A 836      27.293   7.713  -5.937  1.00 15.89           C  
ATOM   2234  CA  PHE A 837      28.249   7.403  -9.603  1.00 17.74           C  
ATOM   2254  CA  GLN A 838      31.103   4.960  -8.856  1.00 21.38           C  
ATOM   2271  CA  ARG A 839      28.546   2.752  -7.072  1.00 17.15           C  
ATOM   2293  CA  TRP A 840      25.897   3.236  -9.784  1.00 16.13           C  
ATOM   2317  CA  LYS A 841      28.339   1.906 -12.379  1.00 17.81           C  
ATOM   2339  CA  GLN A 842      29.186  -1.204 -10.372  1.00 18.93           C  
ATOM   2356  CA  LEU A 843      25.865  -2.780 -11.353  1.00 19.42           C  
ATOM   2375  CA  SER A 844      26.778  -5.944 -13.163  1.00 28.12           C  
ATOM   2385  CA  ASN A 845      23.837  -8.273 -13.194  1.00 38.52           C  
ATOM   2399  CA  PRO A 846      21.237  -6.716 -15.546  1.00 30.18           C  
ATOM   2413  CA  GLN A 847      18.453  -8.103 -13.306  1.00 32.75           C  
ATOM   2430  CA  GLN A 848      19.584  -5.832 -10.566  1.00 25.06           C  
ATOM   2447  CA  GLU A 849      18.281  -2.760 -12.478  1.00 28.68           C  
ATOM   2462  CA  VAL A 850      14.561  -2.050 -12.604  1.00 17.64           C  
ATOM   2478  CA  GLN A 851      12.920   0.887 -14.321  1.00 21.67           C  
ATOM   2495  CA  ASN A 852       9.271   1.953 -14.395  1.00 18.04           C  
ATOM   2509  CA  ILE A 853       7.830   4.689 -16.566  1.00 16.37           C  
ATOM   2528  CA  PHE A 854       4.393   5.453 -15.197  1.00 20.68           C  
ATOM   2548  CA  LYS A 855       1.587   8.019 -15.029  1.00 25.09           C  
ATOM   2570  CA  ALA A 856       1.302  10.185 -11.961  1.00 21.14           C  
ATOM   2580  CA  LYS A 857      -1.515   9.212  -9.629  1.00 25.88           C  
ATOM   2602  CA  HIS A 858      -1.091  12.293  -7.469  1.00 27.80           C  
ATOM   2619  CA  PRO A 859      -0.202  15.933  -8.037  1.00 29.37           C  
ATOM   2633  CA  MET A 860       3.459  16.293  -8.842  1.00 22.63           C  
ATOM   2650  CA  ASP A 861       4.272  18.643  -5.944  1.00 27.19           C  
ATOM   2662  CA  THR A 862       7.975  19.096  -5.276  1.00 26.60           C  
ATOM   2675  CA  GLU A 863       7.901  19.320  -1.496  1.00 25.84           C  
ATOM   2690  CA  ILE A 864       5.510  16.358  -1.123  1.00 22.69           C  
ATOM   2709  CA  THR A 865       7.757  14.334  -3.399  1.00 18.41           C  
ATOM   2722  CA  LYS A 866      10.779  15.150  -1.234  1.00 19.82           C  
ATOM   2744  CA  ALA A 867       8.848  14.133   1.872  1.00 19.38           C  
ATOM   2754  CA  LYS A 868       7.704  10.880   0.293  1.00 17.33           C  
ATOM   2776  CA  ILE A 869      11.269   9.860  -0.644  1.00 16.69           C  
ATOM   2795  CA  ILE A 870      12.548  10.730   2.823  1.00 17.85           C  
ATOM   2814  CA  GLY A 871       9.643   8.796   4.340  1.00 16.45           C  
ATOM   2821  CA  PHE A 872      10.316   5.852   2.090  1.00 13.61           C  
ATOM   2841  CA  GLY A 873      13.606   5.634   3.921  1.00 14.72           C  
ATOM   2848  CA  SER A 874      16.644   6.234   1.713  1.00 14.95           C  
ATOM   2858  CA  ALA A 875      18.819   9.310   1.936  1.00 15.19           C  
ATOM   2868  CA  LEU A 876      17.716  12.090  -0.436  1.00 16.93           C  
ATOM   2887  CA  LEU A 877      20.829  13.199  -2.280  1.00 21.83           C  
ATOM   2906  CA  GLU A 878      21.030  16.658  -3.730  1.00 31.17           C  
ATOM   2921  CA  GLU A 879      23.599  17.746  -6.156  1.00 19.79           C  
ATOM   2936  CA  VAL A 880      23.949  14.339  -7.779  1.00 17.17           C  
ATOM   2952  CA  ASP A 881      21.699  14.479 -10.836  1.00 15.49           C  
ATOM   2964  CA  PRO A 882      22.736  17.680 -12.671  1.00 16.43           C  
ATOM   2978  CA  ASN A 883      19.050  18.248 -13.418  1.00 15.79           C  
ATOM   2992  CA  PRO A 884      17.793  19.822 -10.184  1.00 17.61           C  
ATOM   3006  CA  ALA A 885      14.202  18.779 -10.858  1.00 18.47           C  
ATOM   3016  CA  ASN A 886      15.111  15.093 -10.474  1.00 16.60           C  
ATOM   3030  CA  PHE A 887      15.514  13.180  -7.202  1.00 15.11           C  
ATOM   3050  CA  VAL A 888      18.214  10.753  -6.202  1.00 13.85           C  
ATOM   3066  CA  GLY A 889      18.284   8.337  -3.222  1.00 14.20           C  
ATOM   3073  CA  ALA A 890      20.715   5.915  -1.624  1.00 12.40           C  
ATOM   3083  CA  GLY A 891      20.513   3.526   1.270  1.00 13.26           C  
ATOM   3090  CA  ILE A 892      20.988   0.028   2.554  1.00 12.35           C  
ATOM   3109  CA  ILE A 893      18.113  -2.425   3.152  1.00 11.94           C  
ATOM   3128  CA  HIS A 894      18.910  -4.382   6.297  1.00 13.16           C  
ATOM   3145  CA  THR A 895      17.917  -8.003   6.740  1.00 13.83           C  
ATOM   3158  CA  LYS A 896      19.294 -10.709   9.066  1.00 14.93           C  
ATOM   3180  CA  THR A 897      21.034 -12.615   6.346  1.00 17.11           C  
ATOM   3193  CA  THR A 898      21.934  -9.972   3.707  1.00 17.46           C  
ATOM   3206  CA  GLN A 899      22.489  -6.188   3.516  1.00 14.15           C  
ATOM   3223  CA  ILE A 900      21.404  -4.788   0.159  1.00 13.78           C  
ATOM   3242  CA  GLY A 901      22.804  -1.587  -1.177  1.00 13.67           C  
ATOM   3249  CA  CYS A 902      20.267   0.529  -3.083  1.00 13.52           C  
ATOM   3259  CA  LEU A 903      20.405   3.492  -5.425  1.00 13.65           C  
ATOM   3278  CA  LEU A 904      17.393   5.216  -7.012  1.00 14.84           C  
ATOM   3297  CA  ARG A 905      16.560   7.961  -9.415  1.00 16.45           C  
ATOM   3319  CA  LEU A 906      13.156   9.593  -9.899  1.00 16.19           C  
ATOM   3338  CA  GLU A 907      12.681  11.746 -12.992  1.00 17.25           C  
ATOM   3353  CA  PRO A 908       9.382  13.727 -13.127  1.00 18.79           C  
ATOM   3367  CA  ASN A 909       7.951  14.677 -16.490  1.00 21.92           C  
ATOM   3381  CA  LEU A 910       5.543  17.440 -15.460  1.00 23.76           C  
ATOM   3400  CA  GLN A 911       3.933  18.169 -18.818  1.00 35.65           C  
ATOM   3417  CA  ALA A 912       3.389  14.509 -19.585  1.00 34.23           C  
ATOM   3427  CA  GLN A 913       2.337  13.854 -15.965  1.00 27.77           C  
ATOM   3444  CA  MET A 914       4.697  10.922 -15.909  1.00 24.58           C  
ATOM   3461  CA  TYR A 915       7.675   9.614 -13.940  1.00 16.98           C  
ATOM   3481  CA  ARG A 916      10.701   7.484 -14.739  1.00 17.60           C  
ATOM   3503  CA  LEU A 917      11.881   5.593 -11.661  1.00 16.00           C  
ATOM   3522  CA  THR A 918      15.146   3.615 -11.727  1.00 16.28           C  
ATOM   3535  CA  LEU A 919      16.280   1.199  -9.042  1.00 14.09           C  
ATOM   3554  CA  ARG A 920      19.790  -0.224  -8.959  1.00 13.16           C  
ATOM   3576  CA  THR A 921      20.526  -2.521  -6.011  1.00 13.20           C  
ATOM   3589  CA  SER A 922      22.674  -5.495  -5.099  1.00 15.64           C  
ATOM   3599  CA  LYS A 923      19.723  -7.941  -5.221  1.00 16.63           C  
ATOM   3621  CA  ASP A 924      17.241  -8.369  -8.083  1.00 21.52           C  
ATOM   3633  CA  THR A 925      14.209  -9.072  -5.924  1.00 16.75           C  
ATOM   3646  CA  VAL A 926      14.917  -5.965  -3.805  1.00 14.13           C  
ATOM   3662  CA  SER A 927      15.093  -3.751  -6.910  1.00 14.68           C  
ATOM   3672  CA  GLN A 928      11.739  -5.164  -7.985  1.00 16.10           C  
ATOM   3689  CA  ARG A 929       9.929  -4.791  -4.683  1.00 15.41           C  
ATOM   3711  CA  LEU A 930      11.244  -1.278  -4.022  1.00 14.07           C  
ATOM   3730  CA  CYS A 931      10.272  -0.098  -7.504  1.00 16.27           C  
ATOM   3740  CA  GLU A 932       6.817  -1.644  -7.018  1.00 19.91           C  
ATOM   3755  CA  LEU A 933       6.332   0.097  -3.705  1.00 17.87           C  
ATOM   3774  CA  LEU A 934       7.688   3.514  -4.645  1.00 17.55           C  
ATOM   3793  CA  SER A 935       5.811   3.661  -7.936  1.00 20.46           C  
ATOM   3803  CA  GLU A 936       2.476   3.343  -6.119  1.00 19.35           C  
ATOM   3818  CA  GLN A 937       3.260   6.473  -4.154  1.00 18.40           C  
ATOM   3835  CA  PHE A 938       3.334   8.979  -7.016  1.00 21.82           C  
TER    3836      PHE A 938                                                      
ATOM   3857  CA  SER P 628      27.835  14.810 -20.121  1.00 53.54           C  
ATOM   3863  CA  ASP P 629      25.127  12.798 -18.397  1.00 31.37           C  
ATOM   3871  CA  PRO P 630      26.831  11.177 -15.426  1.00 22.29           C  
ATOM   3878  CA  PHE P 631      24.259   8.361 -15.493  1.00 30.16           C  
ATOM   3889  CA  LYS P 632      25.631   7.411 -18.973  1.00 44.88           C  
TER    3890      LYS P 632                                                      
MASTER      238    0    0    7   18    0    0    6  252    2    0   20          
END                                                                             
